A separate study reported a decrease in baseline CRP levels in COVID-19 (+) patients in whom the severity of depression symptoms decreased compared to COVID-19 (+) patients in whom CRP and depression symptoms were not significantly reduced [172]. The gene discussed is CRP; the disease is major depressive disorder.